Back to User profile » Dr Shaoyong Peng
Paper published by Dr Shaoyong Peng:
Original Research
The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
Wang L, Yang Q, Peng S, Liu X
OncoTargets and Therapy 2019, 12:5359-5373
Published Date: 8 July 2019